JP2012522989A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012522989A5 JP2012522989A5 JP2012503660A JP2012503660A JP2012522989A5 JP 2012522989 A5 JP2012522989 A5 JP 2012522989A5 JP 2012503660 A JP2012503660 A JP 2012503660A JP 2012503660 A JP2012503660 A JP 2012503660A JP 2012522989 A5 JP2012522989 A5 JP 2012522989A5
- Authority
- JP
- Japan
- Prior art keywords
- biomarkers
- subject
- level
- acid
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16533609P | 2009-03-31 | 2009-03-31 | |
| US61/165,336 | 2009-03-31 | ||
| US16657209P | 2009-04-03 | 2009-04-03 | |
| US61/166,572 | 2009-04-03 | ||
| PCT/US2010/029399 WO2010114897A1 (en) | 2009-03-31 | 2010-03-31 | Biomarkers related to insulin resistance and methods using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012522989A JP2012522989A (ja) | 2012-09-27 |
| JP2012522989A5 true JP2012522989A5 (cg-RX-API-DMAC10.html) | 2013-01-17 |
Family
ID=42828685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012503660A Pending JP2012522989A (ja) | 2009-03-31 | 2010-03-31 | インスリン抵抗性に関連するバイオマーカー、及びそれを使用する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120122981A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2414535A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2012522989A (cg-RX-API-DMAC10.html) |
| CN (1) | CN102449161A (cg-RX-API-DMAC10.html) |
| BR (1) | BRPI1013387A2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2010114897A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2172775A4 (en) * | 2007-06-25 | 2010-12-01 | Ajinomoto Kk | METHOD OF EVALUATING VISCERAL GREASE ACCUMULATION |
| EP2164977B1 (en) * | 2007-07-17 | 2013-10-30 | Metabolon, Inc. | Biomarkers for pre-diabetes and methods using the same |
| US10215765B2 (en) | 2010-09-15 | 2019-02-26 | Quest Diagnostics Investments Incorporated | Detection of vitamins A and E by tandem mass spectrometry |
| WO2012058298A1 (en) * | 2010-10-26 | 2012-05-03 | Mayo Foundation For Medical Education And Research | Biomarkers of reduced insulin action |
| KR101303825B1 (ko) * | 2011-06-02 | 2013-09-05 | 연세대학교 산학협력단 | 혈장 대사체를 이용한 제2형 당뇨병 진단 키트 |
| WO2013002381A1 (ja) | 2011-06-30 | 2013-01-03 | 味の素株式会社 | 脂肪性肝疾患の評価方法、脂肪性肝疾患評価装置、脂肪性肝疾患評価方法、脂肪性肝疾患評価プログラム、脂肪性肝疾患評価システム、情報通信端末装置、および脂肪性肝疾患の予防・改善物質の探索方法 |
| EP2756095A4 (en) * | 2011-09-14 | 2015-07-22 | Metabolon Inc | BIOMARKERS RELATED TO INSULIN RESISTANCE AND METHOD OF USE THEREOF |
| EP2642293A1 (en) | 2012-03-22 | 2013-09-25 | Nestec S.A. | 9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing |
| EP2642295A1 (en) * | 2012-03-22 | 2013-09-25 | Nestec S.A. | 1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing |
| US9928345B2 (en) | 2012-06-08 | 2018-03-27 | Liposciences, Inc. | Multiple-marker risk parameters predictive of conversion to diabetes |
| US9470771B2 (en) | 2012-06-08 | 2016-10-18 | Liposcience, Inc. | NMR measurements of NMR biomarker GlycA |
| US9361429B2 (en) | 2012-06-08 | 2016-06-07 | Liposcience, Inc. | Multi-parameter diabetes risk evaluations |
| CN104769434B (zh) * | 2012-08-13 | 2018-01-02 | 亥姆霍兹慕尼黑中心德国研究健康与环境有限责任公司 | 用于2型糖尿病的生物标志物 |
| US20140324460A1 (en) * | 2012-09-26 | 2014-10-30 | Health Diagnostic Laboratory, Inc. | Method for determining and managing total cardiodiabetes risk |
| CN105102977A (zh) | 2012-12-26 | 2015-11-25 | 奎斯特诊断投资公司 | 通过质谱法的c肽检测 |
| EP2943789A1 (en) * | 2013-01-11 | 2015-11-18 | Health Diagnostic Laboratory, Inc. | Method of detection of occult pancreatic beta cell dysfunction in normoglycemic patients |
| JP6404834B2 (ja) * | 2013-01-31 | 2018-10-17 | メタボロン，インコーポレイテッド | インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法 |
| US20140278121A1 (en) * | 2013-03-13 | 2014-09-18 | Robust for Life, Inc. | Systems and methods for network-based calculation and reporting of metabolic risk |
| WO2015057315A1 (en) | 2013-09-04 | 2015-04-23 | Kelly Joseph Michael Lawless | Methods and systems for the detection of disease |
| CN106537145B (zh) * | 2014-04-08 | 2020-08-25 | 麦特博隆股份有限公司 | 用于疾病诊断和健康评估的个体受试者的小分子生物化学特征分析 |
| JP6051257B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
| JP6051258B2 (ja) * | 2015-04-15 | 2016-12-27 | ライオン株式会社 | 脂質異常症への罹患しやすさを試験する方法 |
| JP6873490B2 (ja) * | 2015-10-18 | 2021-05-19 | ジア，ウェイ | 糖尿病関連バイオマーカーおよび糖尿病関連状態の処置 |
| GB201522302D0 (en) * | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for regulating lipid metabolites |
| CN106093430A (zh) * | 2016-06-06 | 2016-11-09 | 上海阿趣生物科技有限公司 | 可用于检测糖尿病的标志物及其用途 |
| CN108318573B (zh) * | 2016-08-16 | 2020-11-13 | 北京毅新博创生物科技有限公司 | 检测胰岛素抵抗的质谱模型的制备方法 |
| CN106442770B (zh) * | 2016-09-05 | 2019-01-18 | 南京医科大学 | 与特发性男性不育相关的精浆代谢小分子标志物及其检测方法和应用 |
| CN106908605B (zh) * | 2017-01-22 | 2019-02-22 | 中国人民解放军军事医学科学院基础医学研究所 | eLtaS蛋白作为预防和治疗胰岛素抵抗相关疾病的药物靶点的应用 |
| CN110998331A (zh) * | 2017-08-17 | 2020-04-10 | 雀巢产品有限公司 | 针对儿童期前驱糖尿病的青春前期标志物 |
| CN108623655B (zh) * | 2018-05-15 | 2020-09-01 | 浙江省农业科学院 | 改善胰岛素抵抗的二肽el及其用途 |
| CN109298084A (zh) * | 2018-07-23 | 2019-02-01 | 上海市东方医院 | 用于检测血清或者血浆中油酸浓度的试剂盒及其制备方法和应用 |
| US20210396766A1 (en) * | 2018-09-27 | 2021-12-23 | Societe Des Produits Nestle S.A. | Markers of risk to develop insulin resistance during childhood and young adulthood |
| CN110887808A (zh) * | 2019-10-28 | 2020-03-17 | 广东省测试分析研究所（中国广州分析测试中心） | 一种红外光谱技术快速检测阿卡波糖发酵过程中的糖源含量的方法 |
| CN112903885B (zh) * | 2019-12-03 | 2022-05-06 | 中国科学院大连化学物理研究所 | 一种筛查糖尿病的联合型代谢标志物的应用及其试剂盒 |
| CN213980949U (zh) | 2020-08-27 | 2021-08-17 | 康明斯电力公司 | 用于发电机组的系统 |
| CN112461986B (zh) * | 2021-02-03 | 2021-06-08 | 首都医科大学附属北京友谊医院 | 一种用于评估空腹血糖受损和2型糖尿病患病风险的整合生物标志物体系 |
| EP3922990B1 (en) | 2021-03-28 | 2024-05-08 | MS Ekspert Sp. z o.o. | System for automatic changing and sealing of disposable chromatographic columns in high-performance liquid chromatography; measurement method and its application in the analysis of biomarker of rare disease |
| CN113929762B (zh) * | 2021-12-16 | 2022-04-26 | 清华大学 | 3-羟基丁酰化和/或3-羟基戊酰化修饰胰岛素及其应用 |
| CN117159717A (zh) * | 2023-09-28 | 2023-12-05 | 广东省人民医院 | Slc25a33在制备预防或治疗葡萄糖代谢相关疾病的药物中的应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR19990007908A (ko) * | 1996-02-20 | 1999-01-25 | 히라다다다시 | 1,5-안히드로글루시톨의 정량법 |
| AU2002312211A1 (en) * | 2001-06-01 | 2002-12-16 | Clingenix, Inc. | Methods and reagents for diagnosis and treatment of insulin resistance and related conditions |
| US7425545B2 (en) * | 2001-07-25 | 2008-09-16 | Isis Pharmaceuticals, Inc. | Modulation of C-reactive protein expression |
| US20100197028A1 (en) * | 2007-02-22 | 2010-08-05 | Tethys Bioscience, Inc. | Metabolic markers of diabetic conditions and methods of use thereof |
| EP2164977B1 (en) * | 2007-07-17 | 2013-10-30 | Metabolon, Inc. | Biomarkers for pre-diabetes and methods using the same |
-
2010
- 2010-03-31 US US13/258,780 patent/US20120122981A1/en not_active Abandoned
- 2010-03-31 BR BRPI1013387-9A patent/BRPI1013387A2/pt not_active Application Discontinuation
- 2010-03-31 WO PCT/US2010/029399 patent/WO2010114897A1/en not_active Ceased
- 2010-03-31 CN CN2010800240217A patent/CN102449161A/zh active Pending
- 2010-03-31 EP EP10759343A patent/EP2414535A4/en not_active Withdrawn
- 2010-03-31 JP JP2012503660A patent/JP2012522989A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015064362A5 (cg-RX-API-DMAC10.html) | ||
| JP6927212B2 (ja) | 軽度認知障害又はアルツハイマー型認知症の評価方法 | |
| Lehmann et al. | Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver | |
| EP2427773B1 (en) | Method of diagnosing asphyxia | |
| Tsang et al. | Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy | |
| JP2010537157A5 (cg-RX-API-DMAC10.html) | ||
| JP6870679B2 (ja) | アルツハイマー型認知症の将来の発症リスクの評価方法 | |
| Zhang et al. | Machine learning applied to serum and cerebrospinal fluid metabolomes revealed altered arginine metabolism in neonatal sepsis with meningoencephalitis | |
| JP2016509222A (ja) | インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法 | |
| Cassol et al. | Altered monoamine and acylcarnitine metabolites in HIV-positive and HIV-negative subjects with depression | |
| JP7123329B2 (ja) | 腎臓病の予後予測方法及びシステム | |
| CN102449161A (zh) | 与胰岛素抵抗有关的生物标记和使用该生物标记的方法 | |
| JP2014532168A5 (cg-RX-API-DMAC10.html) | ||
| Yang et al. | Metabolomics in viral hepatitis: advances and review | |
| Liu et al. | Dynamic proteomic analysis of protein expression profiles in whole brain of Balb/C mice subjected to unpredictable chronic mild stress: implications for depressive disorders and future therapies | |
| JP2012521551A5 (cg-RX-API-DMAC10.html) | ||
| ES2749048T3 (es) | Biomarcadores para evaluar el VIH | |
| CN103837620A (zh) | 一种同时检测人体血浆中多种氨基酸含量的方法 | |
| JP6762529B2 (ja) | 腎臓病の病態バイオマーカー | |
| Bratt et al. | Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin | |
| Han et al. | Plasma advanced glycation endproduct, methylglyoxal-derived hydroimidazolone is elevated in young, complication-free patients with Type 1 diabetes | |
| WO2015030211A1 (ja) | 疲労のバイオマーカーおよびその利用 | |
| Zheng et al. | Urinary and faecal metabolic characteristics in APP/PS1 transgenic mouse model of Alzheimer's disease with and without cognitive decline | |
| Gonçalves et al. | Comparative salivary proteome of hepatitis B-and C-infected patients | |
| CN108508106A (zh) | 生活习惯病的生物标志物及其用途、和存储介质 |